Complete Filing Data
Amplify Commodity Trust reported Investment Owned At Fair Value of $9.38 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Amplify Commodity Trust did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$17.5M | $46.5M | -$35.4M | -$33.4M | $59.3M | $5.6M | -$3.5M | $1.9M | $234.1K |
| Interest Expense | $1.6K | $71.7K | $366.00 | $238.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q4 2020 | Q3 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $6.3M | $22.5M | $5.9M | -$12.3M | -$4.6M | $9.4M | $44.8M | $418.6K | $24.1M | $3.9M | -$22.4M | -$1.1M | $2.6M | -$5.3M | -$278.9K | $1.4M | -$2.0M | -$3.5M | $1.2M | $673.2K | $644.0K | $76.9K | -$251.3K |
| Interest Expense | $1.6K | $108.00 | $194.00 | $21.00 | $14.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity Period Increase Decrease | $43.4M | -$70.6M | $54.2M | -$34.2M | $5.4M | $27.5M | -$35.3M | $32.4M | $3.9M |
| Gain Loss On Sale Of Investments | -$30.6M | $837.0K | $48.1M | -$2.5M | -$4.7M | $2.7M | $52.7K | ||
| Liabilities | $1.3M | $13.9M | $9.6M | $327.3K | $371.8K | $823.4K | $28.7K | ||
| Interest Receivable | $124.0K | $147.8K | $17.2K | $545.00 | $6.3K | $5.2K | $712.00 | ||
| Assets | $42.5M | $79.2M | $56.1M | $49.7M | $16.6M | $55.9M | $20.9M | ||
| Cash Segregated Under Other Regulations | $33.0M | $38.2M | $37.2M | $28.2M | $391.4K | $3.3M | $521.2K | ||
| Stockholders Equity | $65.4M | $114.1M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $38.2M | $50.0M | $28.2M | $3.4M | |||||
| Gain Loss On Investments | -$17.0M | $47.3M | -$34.2M | ||||||
| Other Liabilities | $36.2K | $164.8K | $4.5K | ||||||
| Open Futures Contracts Receivable | $8.6M | $3.2M | $81.7K | $21.8K | |||||
| Investments Fair Value Disclosure | $13.0M | $52.4M | $20.3M | ||||||
| Increase Decrease Of Restricted Investments | -$6.2M | -$43.4M | $30.2M | $3.4M | |||||
| Assets Net | $41.2M | $65.4M | $46.5M | $49.3M | |||||
| Restricted Cash | $33.0M | $50.0M | $28.2M | $3.2M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$5.2M | $21.8M | $25.0M | -$164.9K | |||||
| Other Accrued Liabilities Current And Noncurrent | $366.6K | $46.5K | $3.2K | ||||||
| Change In Unrealized Gain Loss On Investments And Futures Contracts | $12.0M | -$3.6M | -$31.0M | ||||||
| Cash | |||||||||
| Retained Earnings Accumulated Deficit | $42.3M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $50.0M | $28.2M | $3.2M | ||||||
| Cash And Cash Equivalents Period Increase Decrease | -$33.3K | $32.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity Period Increase Decrease | -$11.4M | -$49.3M | $24.8M | $17.3M | -$9.3M | -$7.0M | -$49.6M | $2.2M | -$2.2M | $11.1M | -$7.0M | -$18.7M | $20.9M | $141.8K | -$9.4M | -$28.8M | $823.1K | $9.3M | $9.9M | $5.9M | $5.7M | $8.3M | ||||||||
| Gain Loss On Sale Of Investments | $27.8M | -$18.2M | -$2.9M | -$28.5M | -$3.6M | $10.1M | -$2.9M | -$550.1K | $635.5K | -$3.4M | -$470.8K | -$420.1K | $1.7M | $623.8K | -$108.7K | $147.3K | ||||||||||||||
| Liabilities | $1.3M | $3.7M | $1.4M | $1.1M | $3.1M | $772.2K | $710.9K | $351.9K | $322.0K | $104.4K | $2.5M | $124.4K | $25.3K | $5.0M | $2.4M | $196.1K | $1.8M | |||||||||||||
| Interest Receivable | $92.6K | $115.9K | $182.3K | $181.9K | $90.8K | $88.2K | $49.0K | $70.0K | $145.6K | $84.00 | $2.2K | $2.0K | $2.9K | $6.0K | $3.3K | $8.7K | $3.8K | |||||||||||||
| Assets | $36.5M | $44.0M | $68.6M | $64.2M | $35.4M | $28.1M | $66.2M | $63.5M | $68.3M | $33.4M | $26.1M | $8.2M | $8.2M | $37.1M | $65.3M | $65.8M | $45.4M | |||||||||||||
| Cash Segregated Under Other Regulations | $34.4M | $28.6M | $23.1M | $26.1M | $14.9M | $23.5M | $50.5M | $27.8M | $25.0M | $27.1M | $15.4M | $2.1M | $1.4M | $4.0M | $2.9M | $2.2M | ||||||||||||||
| Stockholders Equity | $35.2M | $40.3M | $67.1M | $63.1M | $32.4M | $27.3M | $41.2M | $65.5M | $63.1M | $68.0M | $36.8M | $35.2M | $46.5M | $25.2M | $33.3M | $49.3M | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $26.1M | $14.9M | $23.5M | $33.0M | $50.6M | $27.8M | $25.0M | $27.5M | $20.4M | $33.1M | $13.5M | $27.1M | $15.4M | $2.1M | $1.4M | $3.2M | ||||||||||||||
| Gain Loss On Investments | $6.4M | $22.5M | $6.1M | -$12.2M | -$4.5M | $9.7M | $45.0M | $622.4K | $15.8M | -$28.5M | ||||||||||||||||||||
| Other Liabilities | $48.9K | $68.9K | $136.6K | $145.6K | $9.5K | $2.0K | $8.1K | $37.1K | $14.1K | $3.2K | $26.3K | |||||||||||||||||||
| Open Futures Contracts Receivable | $1.5M | $3.2M | $15.9K | $86.5K | $48.1K | $872.2K | $1.1M | |||||||||||||||||||||||
| Investments Fair Value Disclosure | $4.8M | $12.9M | $7.4M | $6.1M | $6.7M | $29.9M | $61.3M | $62.0M | $42.1M | |||||||||||||||||||||
| Increase Decrease Of Restricted Investments | -$11.1M | -$7.7M | $8.4M | $5.6M | ||||||||||||||||||||||||||
| Assets Net | $35.2M | $40.3M | $67.1M | $63.1M | $32.4M | $27.3M | $65.5M | $63.1M | $68.0M | |||||||||||||||||||||
| Restricted Cash | $26.1M | $14.9M | $23.5M | $50.6M | $27.8M | $25.0M | $27.5M | $20.4M | $32.0M | $13.5M | $27.1M | $15.4M | $2.1M | $1.4M | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$9.4M | -$13.2M | -$16.8M | -$1.1M | -$1.8M | |||||||||||||||||||||||||
| Other Accrued Liabilities Current And Noncurrent | $223.3K | $239.0K | $371.6K | $458.9K | $561.6K | $513.6K | $4.0K | |||||||||||||||||||||||
| Change In Unrealized Gain Loss On Investments And Futures Contracts | $648.0K | $17.2M | $18.8M | $7.1M | $6.5M | |||||||||||||||||||||||||
| Cash | $1.1M | |||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | $53.5M | $47.2M | $24.8M | $31.3M | $25.4M | $37.7M | ||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $27.8M | $25.0M | $38.2M | $27.5M | $20.4M | $37.2M | ||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$33.3K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Payments For Repurchase Of Common Stock | $122.6M | $90.4M | $12.7M | $62.6M | $8.1M | $7.9M |
| Net Cash Provided By Used In Operating Activities | $65.4M | $16.4M | -$2.5M | $35.1M | -$32.3M | -$3.9M |
| Net Cash Provided By Used In Financing Activities | -$70.6M | $5.4M | $27.5M | -$35.3M | $32.4M | $3.9M |
| Increase Decrease In Accrued Interest Receivable Net | -$23.8K | -$102.00 | -$5.7K | $1.0K | $4.5K | $692.00 |
| Proceeds From Issuance Of Common Stock | $52.0M | $95.8M | $40.2M | $27.3M | $40.5M | $11.8M |
| Increase Decrease In Net Unrealized Loss Gain On Investments | -$13.2M | -$8.5M | $753.6K | $780.5K | -$353.9K | |
| Increase Decrease In Due To Related Parties | $146.6K | $66.9K | -$29.6K | $25.9K | $4.3K | |
| Increase Decrease In Other Accrued Liabilities | $93.5K | $32.6K | $1.3K | $3.2K | ||
| Increase Decrease In Payable On Open Futures Contracts | -$825.3K | -$5.1K | -$321.3K | -$372.0K | ||
| Increase Decrease In Restricted Cash For Operating Activities | -$131.6K | $2.8M | -$20.9K | |||
| Increase Decrease In Due To Related Parties Current | -$128.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|
| Payments For Repurchase Of Common Stock | $10.5M | $11.4M | $12.6M | $20.1M | $9.4M | $2.5M | $1.1M |
| Net Cash Provided By Used In Operating Activities | -$137.6K | -$15.4M | -$27.8M | $17.6M | $7.6M | -$9.3M | -$5.7M |
| Net Cash Provided By Used In Financing Activities | -$9.3M | $2.2M | $11.1M | -$18.7M | -$9.4M | $9.3M | $5.7M |
| Increase Decrease In Accrued Interest Receivable Net | -$35.8K | -$2.2K | $17.9K | -$461.00 | -$3.3K | $3.4K | -$237.00 |
| Proceeds From Issuance Of Common Stock | $1.2M | $13.6M | $23.6M | $1.4M | $11.8M | $6.8M | |
| Increase Decrease In Net Unrealized Loss Gain On Investments | $7.1M | -$761.6K | -$1.5M | -$221.5K | |||
| Increase Decrease In Due To Related Parties | -$657.00 | -$10.6K | $9.1K | $5.2K | |||
| Increase Decrease In Other Accrued Liabilities | -$29.0K | -$1.7K | $856.00 | ||||
| Increase Decrease In Payable On Open Futures Contracts | $5.3M | $279.00 | -$326.5K | -$609.5K | |||
| Increase Decrease In Restricted Cash For Operating Activities | -$1.8M | -$403.6K | -$122.1K | ||||
| Increase Decrease In Due To Related Parties Current | -$34.2K | $12.2K | -$205.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Investment Owned At Fair Value | $9.4M | $40.1M | $17.2M | $55.1M | $33.1M | $16.7M | ||||
| Investment Income Net | -$502.5K | -$806.9K | -$1.2M | -$3.2M | -$1.9M | -$418.0K | $388.0K | -$31.0K | -$172.5K | |
| Sponsor Fees | $175.0K | $175.0K | $136.7K | $131.3K | $155.2K | $200.0K | $210.2K | $90.9K | $50.5K | |
| Noninterest Expense Transfer Agent And Custodian Fees | $126.4K | $108.9K | $75.7K | $64.6K | $83.3K | $119.5K | $117.7K | $72.2K | $55.6K | |
| Wholesale Support Fees | $91.4K | $113.4K | $91.1K | $112.4K | $80.4K | $41.8K | $74.5K | $43.4K | $14.2K | |
| Taxes Other | $210.5K | $324.5K | $221.6K | $461.1K | $101.0K | $100.0K | $189.4K | $97.4K | $71.3K | |
| Regulatory Reporting Fees | $50.0K | $50.0K | $29.0K | $25.0K | $33.4K | $50.0K | $50.0K | $22.4K | $15.7K | |
| Professional Fees | $101.9K | $135.9K | $98.0K | $69.8K | $123.9K | $124.6K | $132.6K | $124.5K | $73.5K | |
| Noninterest Expense Directors Fees | $49.8K | $50.0K | $29.0K | $25.0K | $33.4K | $50.0K | $50.0K | $22.4K | $15.7K | |
| Noninterest Expense Commission Expense | $487.7K | $706.1K | $703.9K | $665.8K | $520.0K | $213.6K | $87.0K | $58.9K | $27.3K | |
| Management Fee Expense | $49.8K | $50.0K | $29.0K | $25.0K | $38.4K | $50.0K | $50.0K | $22.4K | $15.7K | |
| Listing And Calculation Agent Fees | $15.0K | $13.4K | $10.3K | $10.2K | $14.5K | $25.2K | $25.2K | $15.3K | $14.9K | |
| Legal Fees | $164.5K | $156.2K | $52.3K | $45.0K | $86.6K | $80.0K | $80.0K | $47.3K | $35.0K | |
| Investment Income Interest | $1.5M | $1.9M | $1.3M | $33.0K | $8.7K | $151.6K | $1.0M | $464.9K | $67.9K | |
| General Insurance Expense | $12.7K | $24.0K | $17.4K | $15.0K | $20.0K | $30.0K | $30.0K | $19.1K | $15.0K | |
| Gain Loss On Sale Of Derivatives | -$17.0M | $35.3M | -$30.6M | $837.0K | $48.1M | -$2.5M | -$4.7M | $2.7M | $52.7K | |
| Costs And Expenses | $2.3M | $3.0M | $2.5M | $3.3M | $2.1M | $1.3M | $1.4M | $837.9K | $542.1K | |
| Commodity Trading Advisor Fee | $617.2K | $874.4K | $767.7K | $1.1M | $654.0K | $140.8K | $136.9K | $120.8K | $71.0K | |
| Unrealized Gain Loss On Derivatives | -$17.8K | $12.0M | -$3.6M | -$31.0M | $13.2M | $8.5M | $753.6K | -$780.5K | $353.9K | |
| Expenses Absorbed By Sponsor | $119.8K | $277.5K | $77.5K | $136.9K | $673.9K | $661.7K | $253.3K | $230.7K | ||
| Stock Issued During Period Value New Issues | $63.0M | $52.0M | $115.6M | $125.1M | $95.8M | $40.2M | $27.3M | $40.5M | $11.8M | |
| Expense Related To Distribution Or Servicing And Underwriting Fees | $26.5K | $18.2K | $15.7K | $20.8K | $31.4K | $34.0K | $22.0K | $17.6K | ||
| Postage Expense | $68.6K | $15.3K | $39.2K | $11.5K | $21.1K | $52.0K | $31.4K | $25.8K | ||
| Stock Redeemed Or Called During Period Value | $19.5M | $122.6M | -$90.4M | -$12.7M | -$62.6M | -$8.1M | -$7.9M | |||
| Waiver Of Commodity Trading Advisor Fees | $30.0K | $39.2K | $60.8K | $45.5K | $64.0K | $71.0K | ||||
| Unrealized Gain Loss On Derivatives And Commodity Contracts | -$34.2M | -$30.2M | $61.2M | $6.1M | -$3.9M | $1.9M | $406.5K | |||
| Investment Income Investment Expense | $1.2M | $3.2M | $569.5K | $653.9K | $495.9K | $240.4K | ||||
| Other Cost And Expense Operating | $32.2K | $26.1K | $41.6K | $27.4K | $19.4K | |||||
| Realized Investment Gains Losses | $35.3M | $48.1M | -$2.5M | $4.7M | $2.7M | $52.7K | ||||
| Other Operating Income Expense Net | -$2.0M | -$2.7M | -$2.4M | -$3.3M | -$1.9M | -$569.5K | ||||
| Supplies Expense | $29.9K | $30.0K | $38.4K | |||||||
| NJ Filing Fees | $109.9K | $101.5K | $180.2K | |||||||
| Open Option Contracts Written At Fair Value | $4.1K | $19.3K | $70.7K | $3.5K | ||||||
| Due To Related Parties Current And Noncurrent | $88.5K | $21.6K | $51.1K | $25.3K | ||||||
| Waiver Of CTA Fee Amount | $245.2K | $76.0K | $30.0K | |||||||
| Accured Laiblities On Open Future Contracts | $5.1K | $326.5K | $698.4K | |||||||
| Trustee Fees | $5.1K | $5.0K | ||||||||
| Marketing And Advertising Expense | $10.7K | $13.9K | ||||||||
| Due From Customer Acceptances | $22.7K | |||||||||
| Stock Issued During Period Shares New Issues | 4.9M | |||||||||
| Other General Expense | $17.4K | $17.9K | ||||||||
| Distribution Fees | $6.7K | $26.5K | ||||||||
| Additional Paid In Capital | -$1.1M | |||||||||
| Increase In Options Written At Fair Value | -$51.3K | $67.2K | -$109.7K | |||||||
| Printing And Postage Fees | $33.5K | $68.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q1 2017 | Q4 2016 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Owned At Fair Value | $1.9M | $15.1M | $45.3M | $35.4M | $20.4M | $4.5M | $14.1M | $12.3M | $37.1M | $45.4M | $25.2M | $33.3M | $49.3M | $23.7M | $8.0M | $8.2M | $16.2M | $32.1M | $62.9M | $65.6M | $26.6M | $18.7M | $10.7M | |||||||||
| Investment Income Net | -$134.9K | -$94.4K | -$165.4K | -$106.0K | -$66.2K | -$281.4K | -$211.6K | -$203.8K | -$335.6K | -$349.5K | -$356.2K | -$333.1K | -$356.5K | -$100.1K | -$2.1K | $3.0K | $113.9K | $164.6K | $91.5K | $9.3K | -$42.9K | -$35.9K | -$41.1K | |||||||||
| Sponsor Fees | $44.1K | $44.1K | $43.2K | $44.1K | $44.1K | $43.6K | $44.0K | $44.0K | $33.3K | $31.5K | $31.5K | $0.00 | $0.00 | $37.3K | $50.8K | $49.7K | $50.3K | $50.3K | $50.1K | $56.6K | $53.6K | $21.6K | $11.2K | $8.1K | $4.6K | |||||||
| Noninterest Expense Transfer Agent And Custodian Fees | $32.1K | $32.0K | $35.6K | $30.5K | $31.8K | $31.3K | $31.6K | $31.6K | $16.3K | $16.6K | $16.6K | $33.8K | $21.1K | $17.0K | $29.7K | $30.0K | $30.0K | $29.0K | $29.7K | $29.7K | $15.2K | $14.0K | $14.0K | $13.5K | ||||||||
| Wholesale Support Fees | $22.8K | $26.8K | $25.2K | $17.6K | $20.1K | $27.9K | $28.6K | $31.1K | $24.4K | $17.4K | $17.7K | $13.6K | $18.3K | $9.7K | $8.4K | $9.1K | $17.4K | $24.1K | $22.1K | $9.8K | $7.5K | $5.4K | $3.4K | |||||||||
| Taxes Other | $103.7K | $56.1K | $31.5K | $76.8K | $80.9K | $55.3K | $55.9K | $63.0K | $54.2K | $55.5K | $51.7K | $10.7K | $19.4K | $24.9K | $25.1K | $25.1K | $49.3K | $57.6K | $57.6K | $27.8K | $6.3K | $6.3K | $6.2K | |||||||||
| Regulatory Reporting Fees | $12.6K | $12.5K | $12.4K | $12.5K | $12.5K | $12.4K | $12.6K | $12.6K | $6.2K | $6.3K | $6.3K | $13.4K | $12.6K | $12.4K | $12.6K | $12.6K | $12.3K | $12.6K | $12.6K | $6.8K | $1.6K | $1.6K | $1.5K | |||||||||
| Professional Fees | $24.5K | $24.3K | $21.6K | $34.1K | $34.2K | $33.2K | $33.0K | $37.2K | $21.2K | $21.7K | $21.7K | $50.4K | $40.4K | $35.6K | $35.8K | $35.8K | $37.4K | $37.9K | $37.9K | $34.9K | $21.5K | $21.1K | $20.9K | |||||||||
| Noninterest Expense Directors Fees | $12.6K | $12.5K | $12.4K | $12.5K | $12.5K | $12.4K | $12.6K | $12.6K | $6.2K | $6.3K | $6.3K | $8.4K | $12.6K | $12.4K | $12.6K | $12.6K | $12.3K | $12.6K | $12.6K | $6.8K | $1.6K | $1.6K | $1.5K | |||||||||
| Noninterest Expense Commission Expense | $93.8K | $139.0K | $141.2K | $107.4K | $79.6K | $194.6K | $173.1K | $207.8K | $220.2K | $142.5K | $109.6K | $84.0K | $76.5K | $62.5K | $8.1K | $10.2K | $21.4K | $25.6K | $25.4K | $16.4K | $10.7K | $8.2K | $7.7K | |||||||||
| Management Fee Expense | $12.6K | $12.5K | $12.4K | $12.5K | $12.5K | $12.4K | $12.6K | $12.6K | $6.2K | $6.3K | $6.3K | $8.4K | $12.6K | $12.4K | $12.6K | $12.6K | $12.3K | $12.6K | $12.6K | $6.8K | $1.6K | $1.6K | $1.5K | |||||||||
| Listing And Calculation Agent Fees | $3.5K | $3.5K | $3.9K | $4.0K | $3.4K | $4.0K | $4.0K | $4.0K | $2.3K | $2.3K | $2.3K | $3.8K | $6.3K | $6.3K | $6.3K | $6.3K | $6.2K | $6.4K | $6.4K | $3.4K | $3.2K | $3.2K | $2.9K | |||||||||
| Legal Fees | $34.5K | $31.7K | $65.8K | $31.9K | $31.5K | $22.4K | $22.6K | $22.6K | $11.1K | $11.3K | $11.3K | $24.2K | $20.2K | $19.9K | $20.1K | $20.1K | $19.7K | $20.2K | $20.2K | $9.7K | $8.8K | $8.8K | $8.6K | |||||||||
| Investment Income Interest | $318.2K | $430.6K | $420.3K | $217.6K | $300.8K | $392.4K | $465.1K | $544.1K | $417.4K | $117.4K | $87.4K | $574.00 | $6.1K | $36.9K | $37.5K | $56.7K | $261.4K | $384.6K | $295.9K | $118.9K | $80.2K | $53.6K | $17.8K | |||||||||
| General Insurance Expense | $3.3K | $3.3K | $3.1K | $3.1K | $3.3K | $7.5K | $7.5K | $7.5K | $3.7K | $3.8K | $3.8K | $5.0K | $7.6K | $7.5K | $7.5K | $7.5K | $7.4K | $7.6K | $7.6K | $4.1K | $3.8K | $3.8K | $3.7K | |||||||||
| Gain Loss On Sale Of Derivatives | $6.7M | $22.4M | $1.2M | -$9.9M | -$5.1M | $32.0M | $27.8M | -$18.2M | $8.6M | -$2.9M | -$28.5M | -$3.6M | $10.1M | -$2.9M | -$550.1K | $635.5K | -$3.4M | -$470.8K | -$420.1K | $1.7M | $623.8K | -$108.7K | $147.3K | |||||||||
| Costs And Expenses | $572.8K | $619.8K | $618.8K | $534.9K | $543.5K | $732.3K | $758.7K | $846.8K | $774.7K | $505.6K | $471.3K | $384.7K | $466.9K | $330.1K | $258.8K | $265.5K | $335.8K | $379.6K | $372.7K | $199.7K | $145.5K | $127.3K | $106.1K | |||||||||
| Commodity Trading Advisor Fee | $150.4K | $200.5K | $184.2K | $89.6K | $119.1K | $217.4K | $222.6K | $251.1K | $284.2K | $134.4K | $137.7K | $86.3K | $131.8K | $27.9K | $9.7K | $13.7K | $29.6K | $44.3K | $42.5K | $19.2K | $37.5K | $27.1K | $17.1K | |||||||||
| Unrealized Gain Loss On Derivatives | -$258.9K | $153.6K | $4.9M | -$2.2M | $648.0K | -$22.3M | $17.2M | $18.8M | $7.1M | $6.5M | $2.8M | -$7.1M | -$2.3M | $273.3K | $761.6K | $1.3M | -$3.2M | $1.5M | -$1.0M | $63.2K | $221.5K | -$357.5K | ||||||||||
| Expenses Absorbed By Sponsor | $102.0K | $88.7K | $28.0K | $121.7K | $73.8K | $37.4K | $74.6K | $86.1K | $0.00 | $32.5K | $0.00 | $167.9K | $212.6K | $202.2K | $179.9K | $149.1K | $155.3K | $70.5K | $10.7K | $30.2K | ||||||||||||
| Stock Issued During Period Value New Issues | $2.5M | $13.5M | $27.2M | $22.0M | $1.2M | $29.0M | $537.3K | $13.6M | $11.6M | $23.6M | $653.7K | $1.4M | $21.6M | $1.2M | $1.8M | $12.5M | $11.8M | $11.0M | $10.5M | $6.8M | $8.3M | |||||||||||
| Expense Related To Distribution Or Servicing And Underwriting Fees | $6.2K | $5.8K | $7.8K | $7.9K | $7.9K | $3.9K | $4.0K | $4.0K | $5.2K | $7.8K | $7.8K | $7.9K | $7.9K | $8.4K | $8.6K | $8.6K | $4.7K | $4.4K | $4.4K | $3.7K | ||||||||||||
| Postage Expense | $16.1K | $16.4K | $4.9K | $5.2K | $3.9K | $4.0K | $3.4K | $3.5K | $5.3K | $5.2K | $5.3K | $5.3K | $12.8K | $13.1K | $13.1K | $6.9K | $6.5K | $6.6K | $5.5K | |||||||||||||
| Stock Redeemed Or Called During Period Value | $13.9M | $62.8M | $2.4M | $4.8M | $10.5M | $36.0M | -$7.7M | -$20.1M | -$695.6K | -$1.0M | -$9.4M | -$30.6M | -$11.7M | -$2.5M | -$1.1M | -$4.7M | -$1.1M | |||||||||||||||
| Waiver Of Commodity Trading Advisor Fees | $7.3K | $12.8K | $38.7K | $27.6K | $18.4K | $25.2K | $6.6K | $9.7K | $8.4K | $10.5K | $13.0K | $1.1K | $22.3K | $27.1K | $17.1K | $13.1K | $16.3K | |||||||||||||||
| Unrealized Gain Loss On Derivatives And Commodity Contracts | $45.0M | $622.4K | $4.2M | -$22.0M | -$788.9K | $3.0M | -$5.2M | -$276.8K | $1.4M | -$2.1M | -$3.7M | $1.1M | $663.9K | $686.9K | $112.8K | -$210.2K | ||||||||||||||||
| Investment Income Investment Expense | $211.6K | $203.8K | $349.5K | $356.2K | $333.7K | $362.6K | $137.1K | $39.6K | $53.6K | $147.5K | $220.0K | $204.4K | $109.6K | $123.2K | $89.5K | $58.9K | ||||||||||||||||
| Other Cost And Expense Operating | $4.3K | $6.3K | $6.3K | $6.4K | $6.4K | $10.1K | $10.3K | $10.3K | $5.7K | $5.3K | $5.6K | $3.7K | ||||||||||||||||||||
| Realized Investment Gains Losses | -$18.2M | $10.1M | $635.5K | -$420.1K | -$108.7K | |||||||||||||||||||||||||||
| Other Operating Income Expense Net | -$453.1K | -$525.0K | -$585.7K | -$323.6K | -$367.1K | -$673.7K | -$676.8K | -$747.9K | -$752.9K | -$466.9K | -$443.6K | |||||||||||||||||||||
| Supplies Expense | $7.5K | $7.5K | $7.4K | $7.5K | $7.5K | $6.0K | $6.1K | $12.0K | $8.9K | $9.1K | ||||||||||||||||||||||
| NJ Filing Fees | $1.5K | $24.8K | $25.3K | $25.3K | $30.4K | $62.6K | $73.3K | $62.2K | $26.2K | |||||||||||||||||||||||
| Open Option Contracts Written At Fair Value | $3.1K | $18.9K | $5.9K | $11.6K | $53.7K | $251.6K | $42.9K | $56.5K | ||||||||||||||||||||||||
| Due To Related Parties Current And Noncurrent | $87.8K | $45.7K | $10.1K | $10.9K | $37.2K | $63.7K | $60.3K | $36.3K | ||||||||||||||||||||||||
| Waiver Of CTA Fee Amount | $17.6K | $6.1K | $5.1K | $89.6K | $102.6K | $21.2K | $7.3K | $12.8K | $21.7K | |||||||||||||||||||||||
| Accured Laiblities On Open Future Contracts | $5.4K | $2.4M | $105.1K | $2.1M | $88.9K | $582.9K | ||||||||||||||||||||||||||
| Trustee Fees | $1.3K | $1.3K | $1.3K | $1.3K | $1.3K | |||||||||||||||||||||||||||
| Marketing And Advertising Expense | $7.8K | $7.8K | $2.6K | $2.6K | $2.6K | |||||||||||||||||||||||||||
| Due From Customer Acceptances | $28.7K | $24.4K | $25.7K | $34.0K | $24.5K | $19.2K | ||||||||||||||||||||||||||
| Stock Issued During Period Shares New Issues | 7.9M | 1.5M | 2.6M | 1.9M | 1.3M | |||||||||||||||||||||||||||
| Other General Expense | $13.7K | $761.00 | $3.0K | $3.7K | $3.8K | $3.8K | ||||||||||||||||||||||||||
| Distribution Fees | $1.7K | $1.7K | -$5.4K | $6.2K | $5.8K | $7.8K | ||||||||||||||||||||||||||
| Additional Paid In Capital | -$18.4M | -$6.9M | $42.4M | $31.7M | $6.9M | -$10.4M | ||||||||||||||||||||||||||
| Increase In Options Written At Fair Value | -$27.8K | $5.0K | ||||||||||||||||||||||||||||||
| Printing And Postage Fees | $7.9K | $8.8K | $1.0K | $16.1K | $16.4K |
Most recent annual filing with the SEC: September 26, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.